Workflow
永赢科技智选混合基金
icon
Search documents
惊呆了!九个月暴增440倍!
天天基金网· 2025-10-23 08:14
牛市来了还没上车?上天天基金APP搜索777注册即可领500元券包,优选基金10元起投!限 量发放!先到先得! 最新披露的公募基金2025年三季报显示,多只基金规模大幅增长。其中,永赢科技智选混合基金 规模增至115亿元,较去年底增长超440倍。 从最新观点看,基金经理普遍认为,接下来权益资产配置价值依然值得关注,有较多投资机会可以 把握。 多只绩优基金规模大增 三季度,多只基金规模实现跃升。 永赢科技智选混合基金三季报显示,截至三季度末,该基金规模超过了115亿元。值得注意的是, 2024年底永赢科技智选混合基金规模只有0.2609亿元。这意味着,短短9个月时间,永赢科技智选 混合基金规模暴增超440倍。 | 主要财务指标 | 报告期(2025年07月01日-2025年09月30日) | | | --- | --- | --- | | | 永赢科技智选混合发起 A | 永赢科技智选混合发起 C | | 1. 本期已实现收益 | 417, 374, 279. 11 | 2,082,525,889.53 | | 2. 本期利润 | 733, 228, 228. 59 | 3, 981, 899, 341. 77 ...
九个月 暴增440倍!
最新披露的公募基金2025年三季报显示,多只基金规模大幅增长。其中,永赢科技智选混合基金规模增至115亿元,较去年底增长超440倍。 多只绩优基金规模大增 三季度,多只基金规模实现跃升。 永赢科技智选混合基金三季报显示,截至三季度末,该基金规模超过了115亿元。值得注意的是,2024年底永赢科技智选混合基金规模只有0.2609亿元。 这意味着,短短9个月时间,永赢科技智选混合基金规模暴增超440倍。 | 主要财务指标 | 报告期(2025年07月01日-2025年09月30日) | | | --- | --- | --- | | | 永赢科技智选混合发起 A | 永赢科技智选混合发起 C | | 1. 本期已实现收益 | 417,374,279,11 | 2,082,525,889.53 | | 2. 本期利润 | 733, 228, 228. 59 | 3,981,899,341.77 | | 3. 加权平均基金份额本期利润 | 1. 6726 | 1.7118 | | 4. 期末基金资产净值 | 2, 278, 322, 574. 61 | 9, 242, 901, 116. 95 | | 5. 期末基金 ...
结构性行情持续演绎 基金年内业绩首尾相差近150个百分点
Core Insights - The average return of actively managed equity funds has significantly improved, reaching 15.1% year-to-date as of August 6, with over 500 funds hitting historical net asset value highs [1][2] - There is a stark performance disparity among funds, with top performers achieving returns close to 130% while laggards have seen declines exceeding 18% [1][3] - The strong performance of leading funds is attributed to successful investments in sectors such as innovative pharmaceuticals, technology, and new consumer trends [2][3] Performance Summary - As of August 6, 127 actively managed equity funds have returns exceeding 50%, with 23 funds surpassing 80%, and 6 funds doubling their net asset value this year [2] - Specific funds like Changcheng Pharmaceutical Industry Select Mixed Fund and Bank of China Hong Kong Stock Connect Pharmaceutical Mixed Fund have returns of 129.97% and 117.54% respectively [2] - Funds focusing on innovative pharmaceuticals have been particularly successful, with several funds achieving returns over 90% in related sectors [2] Fund Management Trends - A significant number of high-performing funds are now implementing purchase limits due to increased investor interest and inflows, with nearly 30 funds announcing restrictions on large subscriptions [4] - Recent fund issuance has also seen a resurgence, with several funds raising over 1 billion yuan, indicating a growing market interest [4] - The trend of increasing fund management activity suggests that equity funds are becoming a key avenue for reallocating household savings [4] Market Outlook - The ongoing supportive policies for the capital market are expected to enhance investor risk appetite, with potential catalysts in technology, high-end manufacturing, and consumer sectors [5] - The release of semi-annual earnings from listed companies is anticipated to improve the effectiveness of investment strategies, particularly in sectors with concentrated catalysts [5]